1. Home
  2. TNGX vs HRTG Comparison

TNGX vs HRTG Comparison

Compare TNGX & HRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • HRTG
  • Stock Information
  • Founded
  • TNGX 2014
  • HRTG 2012
  • Country
  • TNGX United States
  • HRTG United States
  • Employees
  • TNGX N/A
  • HRTG N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • HRTG Property-Casualty Insurers
  • Sector
  • TNGX Health Care
  • HRTG Finance
  • Exchange
  • TNGX Nasdaq
  • HRTG Nasdaq
  • Market Cap
  • TNGX 413.6M
  • HRTG 457.2M
  • IPO Year
  • TNGX N/A
  • HRTG 2014
  • Fundamental
  • Price
  • TNGX $3.92
  • HRTG $12.40
  • Analyst Decision
  • TNGX Strong Buy
  • HRTG Buy
  • Analyst Count
  • TNGX 8
  • HRTG 3
  • Target Price
  • TNGX $13.14
  • HRTG $12.50
  • AVG Volume (30 Days)
  • TNGX 3.5M
  • HRTG 323.6K
  • Earning Date
  • TNGX 11-06-2024
  • HRTG 11-06-2024
  • Dividend Yield
  • TNGX N/A
  • HRTG N/A
  • EPS Growth
  • TNGX N/A
  • HRTG 135.16
  • EPS
  • TNGX N/A
  • HRTG 2.43
  • Revenue
  • TNGX $43,383,000.00
  • HRTG $793,687,000.00
  • Revenue This Year
  • TNGX $25.55
  • HRTG N/A
  • Revenue Next Year
  • TNGX N/A
  • HRTG $9.21
  • P/E Ratio
  • TNGX N/A
  • HRTG $5.09
  • Revenue Growth
  • TNGX 15.67
  • HRTG 9.76
  • 52 Week Low
  • TNGX $2.70
  • HRTG $5.51
  • 52 Week High
  • TNGX $13.01
  • HRTG $16.90
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 39.26
  • HRTG 58.23
  • Support Level
  • TNGX $3.54
  • HRTG $11.41
  • Resistance Level
  • TNGX $4.22
  • HRTG $12.45
  • Average True Range (ATR)
  • TNGX 0.53
  • HRTG 0.76
  • MACD
  • TNGX 0.13
  • HRTG 0.16
  • Stochastic Oscillator
  • TNGX 48.61
  • HRTG 88.73

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About HRTG Heritage Insurance Holdings Inc.

Heritage Insurance Holdings Inc is a regional property and casualty insurance company that offers a variety of personal and commercial insurance products. Through its subsidiaries, Heritage Property & Casualty Insurance, Narragansett Bay Insurance, and Zephyr Insurance, the company issues personal residential property insurance in various states in the United States. It also offers commercial residential insurance predominantly for its Florida properties. Heritage Insurance manages insurance underwriting, customer services, actuarial analysis, distribution, and claims processing internally.

Share on Social Networks: